Report cover image

Cell Biology Research Market, Global, 2024–2030

Publisher Frost & Sullivan
Published Aug 18, 2025
SKU # MC20315120

Description

In the study, Frost & Sullivan examines the global cell biology research market. The market is projected to register high growth between 2024 and 2030, reaching significant revenue milestones. This growth reflects accelerating innovation across instrumentation, consumables, and software platforms, with a firm push from data-driven research models, increased academic and biopharma collaboration, and the digitalization of lab workflows. In addition, the emergence of new cell-based therapies and the increasing complexity of biological research call for more sophisticated tools and workflows.

This analysis includes:
• Factors driving and restraining the adoption of cell biology research solutions
• Segmentation by product type (instruments, consumables and reagents, software), end use (pharma, academia and research, clinical labs), technology (single-cell analysis, live-cell imaging, high-throughput screening, flow cytometry, cell culture, CRISPR and gene editing, others), and region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa)
• Notable companies in each product segment and technology

Frost & Sullivan also identifies the major growth opportunities in the cell biology research space by evaluating the industry segments, emerging business models, and revenues and forecasts.

The study period is 2024–2030, with 2024 as the base year and 2025–2030 as the forecast period.

Table of Contents

    • Scope of Analysis
    • Segmentation
    • Why is it Increasingly Difficult to Grow?
    • The Strategic Imperative 8
    • The Impact of the Top 3 Strategic Imperatives on the Cell Biology Research Industry
    • Competitive Environment
    • Key Competitors
    • Growth Metrics
    • Growth Drivers
    • Growth Restraints
    • Forecast Considerations
    • Revenue Forecast
    • Revenue Forecast by Product
    • Revenue Forecast by End User
    • Revenue Forecast by Technology
    • Revenue Forecast by Region
    • Revenue Forecast Analysis
    • Revenue Forecast Analysis by Product
    • Revenue Forecast Analysis by End User
    • Revenue Forecast Analysis by Technology
    • Revenue Forecast Analysis by Region
    • Pricing Trends and Forecast Analysis
    • Revenue Share
    • Company Matrix
    • Company Portfolio
    • Revenue Share Analysis
    • Companies to Watch: Single-Cell Analysis
    • Companies to Watch: Live-Cell Imaging
    • Companies to Watch: High-Throughput Screening
    • Companies to Watch: Flow Cytometry
    • Companies to Watch: Cell Culture
    • Companies to Watch: CRISPR and Gene Editing
    • Companies to Watch: Others*
    • Growth Metrics
    • Revenue Forecast
    • Revenue Forecast by Region
    • Forecast Analysis
    • Growth Metrics
    • Revenue Forecast
    • Revenue Forecast by Region
    • Forecast Analysis
    • Growth Metrics
    • Revenue Forecast
    • Revenue Forecast by Region
    • Forecast Analysis
    • Growth Opportunity 1: Create Software Solutions for Workflow Integration
    • Growth Opportunity 2: Combine Single-Cell Analysis with Genomics and Gene Editing Tools
    • Growth Opportunity 3: Develop Custom Solutions for Biopharma and Translational Research
    • Benefits and Impacts of Growth Opportunities
    • Next Steps
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.